FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions

The U.S. Food and Drug Administration today approved Cytalux (pafolacianine), an imaging drug intended to assist surgeons in identifying ovarian cancer lesions. The drug is...
The post FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions appeared first on SciTechDaily.